Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
PETROS PHARMACEUTICALS INC
PTPI | US
0.01
USD-0.00
-22.50%
PTPI | US
About PETROS PHARMACEUTICALS INC
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
30/06/2024
As of date
21/04/2026
Close
0.01
Open
0.01
High
0.01
Low
0.01
Petros Pharmaceuticals Inc. a pharmaceutical company focuses on men's health therapeutics in the United States and internationally. It operates through two segments Prescription Medications and Medical Devices. The company engages in the commercialization and development of Stendra an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100 a novel and patented topical formulation candidate for the treatment of acute Peyronie's disease. The company offers men's health products including vacuum erection devices PreBoost VenoSeal penile injections and urinary tract infection tests for the treatment of erectile dysfunction. Petros Pharmaceuticals Inc. is based in New York New York.
View LessPTPI | US
Risk
201.3
Sharpe
-0.62
Luna's Score
33/100
Recommendation
Sell
Luna says (PTPI | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
232.9%1 month
201.3%3 months
148.1%6 months
160.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.38
Debt to equity
0.83
Debt to assets
0.30
Ent. to EBITDA
-0.15
Ent. to rev.
1.06
PEG
-
Other Fundamentals
EBITDA
-10.13M
MarketCap
59.56K
MarketCap(USD)
59.56K
Div. yield
-
Op. margin
-160.46
Erngs. growth
-
Rev. growth
-28.70
Ret. on equity
-63.77
Short ratio
3.85
Short perc.
3.61
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.00
Range1M
0.00
Range3M
0.00
Volumes: Market Activity
Rel. volume
0.66
Price X volume
137.80
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.15 | - | Cheaper |
| Ent. to Revenue | 1.06 | - | Cheaper |
| PE Ratio | - | 30.05 | - |
| Price to Book | 0.38 | 13.15 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 148.13 | - | Riskier |
| Debt to Equity | 0.83 | -1.88 | Expensive |
| Debt to Assets | 0.30 | 0.48 | Cheaper |
| Market Cap | 59.56K | - | Emerging |
